Overview A Phase 2 in Adult Subjects With Hereditary Angioedema Status: RECRUITING Trial end date: 2028-03-30 Target enrollment: Participant gender: Summary A Phase 2 in Adult Subjects with Hereditary AngioedemaPhase: PHASE2 Details Lead Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd.